{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-029000","form_type":"8-K","ticker":"CPHI","cik":"0001106644","company_name":"CHINA PHARMA HOLDINGS, INC.","filed_at":"2025-04-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.535503+00:00","generated_at":"2026-05-23T20:39:46.487086+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"China Pharma Holdings announces 1-for-10 reverse stock split effective April 15, 2025","bullets":["Reverse stock split at ratio 1:10, effective April 15, 2025, trading to begin on split-adjusted basis.","Board fixed ratio on March 26, 2025; authorized by board October 22, 2024 and stockholders December 22, 2024.","No fractional shares issued; any fractional shares rounded up to whole number.","Stockholders' percentage interest remains unchanged except for fractional share adjustments."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-029000","json":"https://secwatch.observer/filing/0001213900-25-029000.json","markdown":"https://secwatch.observer/filing/0001213900-25-029000.md","text":"https://secwatch.observer/filing/0001213900-25-029000.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1106644/000121390025029000/0001213900-25-029000-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1106644/000121390025029000/ea0237208-8k_china.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T20:39:46.487086+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}